1The Cardiac Arrhythmia Suppression Trial(CAST) Investigators.Preliminary report:effect of encainide and flecainide on mortality in a randomized trial of arrhythmia soppresion after myocardial infarction.N Engl J Mcd,1989,321(4):406.
1Antman EM, Anbe DT, Armstrong PW,et al.ACC/AHA guidlines for the management of patients with ST-elevation myocardial infarction-executive summary[J]. Circulation,2004,110:588
3Goldschlager N, Epstein AE, Naccarelli G, et al. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology[J]. Arch Intern Med,2000,160:1 741
4The American Heart Association in Collaboration with the International Liais on Committee on Resuscitation. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 6: Advance cardiovascular life support. Section 5: Phamacology I: Agents for Arrhythmias[J]. Circulation, 2000, 102(Suppl 8): I 112
5Fuster V, Rydén LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation[J]. Eur Heart J,2001,22:1 852
7Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation[J]. N Engl J Med, 2002,347:1 825
2Gjesdal K. Amiodarone still a useful antiarrhythmie drug[J].Tidsskr Nor Laegeforen ,2008,128(13):1532-1533.
3Vassallo P, Trohman RG . Prescribing amiodarone: an evi- dence-based review of clinical indications[J].JAMA , 2007, 298 (11):1312-1322.
4Kannel WB,Abbott RD,Savage DD,et al.Epidemiologic features of chronic atrial fibrillation:the Framingham study.N Engl J Med,1982,306(7):1018-1022.
5Botto GL,Boniniw,Broffoni T,et al.Regular ventricular rhythms before conversion of recent,onset atrial fibrillation to sinus thythm.Pacing Clin Electrophysiol,1994,17(7):2114-2117.
6Galve E,Rius T,Ballaster R,et al.Intravenous amiodrone in the treatment of receut onset a trial fibrillation:resuit of arandomized,controlled trial.Jam Coil Cardiol,1996,28(1):130-136.